1. Home
  2. CHI vs ABCL Comparison

CHI vs ABCL Comparison

Compare CHI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHI
  • ABCL
  • Stock Information
  • Founded
  • CHI 2002
  • ABCL 2012
  • Country
  • CHI United States
  • ABCL Canada
  • Employees
  • CHI N/A
  • ABCL N/A
  • Industry
  • CHI Investment Managers
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHI Finance
  • ABCL Health Care
  • Exchange
  • CHI Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • CHI 879.5M
  • ABCL 719.0M
  • IPO Year
  • CHI N/A
  • ABCL 2020
  • Fundamental
  • Price
  • CHI $12.04
  • ABCL $2.72
  • Analyst Decision
  • CHI
  • ABCL Buy
  • Analyst Count
  • CHI 0
  • ABCL 3
  • Target Price
  • CHI N/A
  • ABCL $8.50
  • AVG Volume (30 Days)
  • CHI 186.2K
  • ABCL 2.5M
  • Earning Date
  • CHI 01-01-0001
  • ABCL 11-04-2024
  • Dividend Yield
  • CHI 9.90%
  • ABCL N/A
  • EPS Growth
  • CHI N/A
  • ABCL N/A
  • EPS
  • CHI N/A
  • ABCL N/A
  • Revenue
  • CHI N/A
  • ABCL $32,962,000.00
  • Revenue This Year
  • CHI N/A
  • ABCL N/A
  • Revenue Next Year
  • CHI N/A
  • ABCL $38.78
  • P/E Ratio
  • CHI N/A
  • ABCL N/A
  • Revenue Growth
  • CHI N/A
  • ABCL N/A
  • 52 Week Low
  • CHI $9.70
  • ABCL $2.34
  • 52 Week High
  • CHI $11.61
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • CHI 59.96
  • ABCL 49.01
  • Support Level
  • CHI $11.60
  • ABCL $2.57
  • Resistance Level
  • CHI $12.08
  • ABCL $3.18
  • Average True Range (ATR)
  • CHI 0.17
  • ABCL 0.19
  • MACD
  • CHI 0.03
  • ABCL -0.02
  • Stochastic Oscillator
  • CHI 87.26
  • ABCL 32.35

About CHI Calamos Convertible Opportunities and Income Fund

CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND operates as a closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in convertible securities and high-yield securities.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: